Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Kala Pharmaceuticals, Inc. Kala Pharmaceuticals Announces Name Change to KALA BIO August 02, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 19, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 23, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference June 02, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Combangio, Inc., a Wholly Owned Subsidiary of Kala Pharmaceuticals, Awarded $15 Million by California Institute for Regenerative Medicine to Support Ongoing KPI-012 Program for the Treatment of PCED April 28, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect April 12, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor March 29, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED March 27, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference March 08, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update March 03, 2023 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED December 27, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces Submission of Investigational New Drug Application for KPI-012 for the Treatment of Persistent Corneal Epithelial Defect November 28, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing November 28, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 08, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces Appointment of Marjan Farid, M.D., to its Board of Directors November 01, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Announces Reverse Stock Split October 20, 2022 From Kala Pharmaceuticals, Inc. Via GlobeNewswire Tickers KALA Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 18, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals Announces EYSUVIS® Now Covered by OptumRx June 03, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare Conference May 27, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) May 20, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference May 06, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update May 05, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call April 28, 2021 From Kala Pharmaceuticals, Inc. Via Business Wire Tickers KALA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.